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Intestinal obstruction after liver transplant is a rare complication, with diverse clinical manifestations. Intestinal adhesion is 
the most common cause. However, internal hernia, abdominal wall hernia, and neoplasm are also reported. Intussusception 
is another rare cause of intestinal obstruction, which has been reported primarily in pediatric patients. Herein, we report a 
case of intestinal obstruction from intussusception in an adult liver transplant patient associated with post-transplant lym-
phoproliferative disorder.
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INTRODUCTION
In adult general surgery setting, postoperative adhesive 
obstruction which needs for laparotomy is reported in 
small portion of patients. However, bowel obstruction af-
ter liver transplantation is an unusual complication. Intus-
susception is a rare cause of intestinal obstruction in adults 
compare to the pediatric population. In adults, some un-
derlying cause such as a benign or malignant tumor is 
present at the leading point of the intussusception in about 
90% cases. Therefore, surgery is needed for the treatment 
of intussusception in most cases. Post transplant lympho-
proliferative disorder (PTLD) is a relatively common ma-
lignancy after transplantation and accounts for up to 10% 
of all solid organ transplant recipients. We present a rare 
case of intussusception associated with PTLD in adult liv-
er transplant patient.
CASE REPORT
A fifty-year-old male underwent deceased donor liver 
transplantation in September 2003 due to liver cirrhosis, 
secondary to chronic hepatitis C infection. The donor was PTLD presented as intussusception
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Fig. 4. (A, B) CD20 and CD79a, tumor cells displaying B-cell 
markers by Immunohistochemistry (H&E, ×200). (C, D) CD10 and 
BCL-6, tumor cells displaying germinal center phenotype by 
immunohistochemistry (H&E, ×200).
Fig. 1. Simple abdominal X-ray presents multiple dilated small 
bowel loops.
Fig. 2. Operative finding shows 4 × 4 cm sized mass which located 
300 cm distal from ligament of Treitz and occluded the lumen of the 
jejunum by formation of intussusception. 
Fig. 3. (A, B) Low power view of tumor cells infiltrating the mucosal 
wall and approaching the serosa (H&E, ×40). (C) High power view 
of the tumor cells displaying prominent centroblastic features 
(H&E, ×400).
a 27 year-old male who died of head trauma. Both donor 
and recipient were positive for cytomegalovirus and 
Epstein-Barr virus (EBV) antibodies in the serum. Cold is-
chemia time was 5 hours 43 minutes. Daclizumab (anti- 
CD25 monoclonal antibody) 1 mg/kg was used for in-
duction therapy. Tacrolimus and steroids were used as 
maintenance immunosuppressan t s .  S t e r o i d s  w e r e  t a -
pered off 3 months after transplant. There was no episode 
of acute rejection or evidence of recurrent hepatitis C until 
the patient developed PTLD. 
He was admitted to the hospital with acute abdominal 
pain 7 years after transplant. Simple abdominal X-ray 
showed multiple dilated small bowel loops with air fluid Sun Hyung Joo, et al.
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levels, which were resolved with nasogastric tube decom-
pression within 24 hours. No further study or specific 
treatment was given, and the patient was discharged. The 
patient required re-admission 7 days later with symptoms 
and signs of complete intestinal obstruction. Simple ab-
dominal X-ray showed findings similar to those on the 
previous admission (Fig. 1). Because this was the second 
episode within a short period of time, an emergency lapa-
rotomy was performed without further radiologic imag-
ing, such as abdominal computed tomography (CT) scan. 
Operative finding revealed intussusception of the jeju-
num, approximately 300 cm distal from ligament of Treitz 
(Fig. 2). No abnormal lymphadenopathy was visualized in 
the mesentery of the small intestine. Simple resection of 
the small bowel was performed since no other pathology 
was found in the abdominal cavity. Post-operative recov-
ery was uneventful, and the patient was discharged 4 days 
after surgery. 
The surgical specimen showed a tan firm, well-circum-
scribed mass, measuring 4 × 3.9 cm, which occluded the lu-
men of the jejunum. Microscopically, the tumor extended 
from the mucosal surface through the muscularis layers 
and approached the serosal surface. The tumor cells were 
large, had high nuclear to cytoplasmic ratio, delicate chro-
matin, and exhibited prominent centroblastic features 
(Fig. 3). The tumor cells were positive for CD20, CD79a, 
CD10, and BCL-6 by immunohistochemistry (Fig. 4). They 
were negative for CD3, CD5, BCL-2, S-100 and keratin. 
Ki-67 index was high (greater than 90%). Fluorescent in 
situ hybridization analysis was positive for translocation 
between chromosomes 8 and 14 (IGH/MYC) in 10% of in-
terphase nuclei, and negative for translocation between 
chromosomes 14 and 18. In situ hybridization demon-
strated that the tumor was negative for EBV. Based upon 
these things, a diffuse large B-cell lymphoma of germinal 
center phenotype with MYC translocation was diagnosed.
A complete staging evaluation was performed, which 
confirmed stage IIAE disease with an international prog-
nostic index score of 0. The patient received 6 cycles of che-
motherapy consisting of rituximab (anti-CD20 monoclonal 
antibody) 375 mg/m
2, cyclophosphamide 750 mg/m
2, dox-
orubicin 50 mg/m
2, vincristine 1.4 mg/m
2 (capped at 2 mg) 
IV, and prednisone 100 mg orally daily for 5 days (R- 
CHOP) given every 14 days, followed by Neupogen 
(Amgen Inc., Thousand Oaks, CA, USA) growth factor 
support. The patient tolerated the treatment without any 
major adverse effects and achieved a complete remission. 
DISCUSSION
Postoperative intra-abdominal adhesions represent the 
most common cause of intestinal obstruction in non-trans-
plant operations, with a very small percentage (3.3%) re-
quiring laparotomy [1]. Intestinal obstruction after liver 
transplant has not been extensively studied, but seems to 
be a rare complication. Blachar and Federle [2] reported a 
1.2% incidence of intestinal obstruction in 4,001 liver 
transplantations performed during a 15-year period. Un-
usual causes such as internal hernias around the infrarenal 
arterial conduits or through the mesenteric defect for 
Roux-en-Y hepaticojejunostomy, diaphragmatic hernias, 
and intussusceptions are reported [3-5]. In pediatric liver 
transplant patients, there are a few reports describing in-
tussusception associated with PTLD, but these are ex-
tremely rare in adult patients to the best of our knowledge. 
Clinical presentation of the intussusception is usually in-
testinal obstruction; however jaundice was reported when 
it occurred at the Roux limb or jejunojejunostomy which 
mimicked biliary obstruction [4,5]. In adults, most in-
tussusception has a benign or malignant tumor as a lead-
ing point, which necessitates surgical resection [6]. In cas-
es of incidental or asymptomatic intussusception in pedia-
tric liver transplant patients, close follow-up without sur-
gical intervention was reported as a possible treatment op-
tion [4,7]. In general, intestinal obstruction after liver 
transplant is rare; but unusual causes, other than adhe-
sions, are more frequently reported than in non-transplant 
surgery . Laparotomy should be always considered as a 
treatment option. 
PTLD is a relatively common malignancy after trans-
plantation and occurs in up to 10% of all solid organ trans-
plant recipients [8]. It is the most common cause of can-
cer-related mortality after solid organ transplantation in 
both children and adults. The incidence of PTLD after sol-
id organ transplantation varies according to the type of PTLD presented as intussusception
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graft and differs between children and adults. The in-
cidence of PTLD in adult liver transplant recipients has 
been reported as 1 to 3%. EBV induced PTLD is well docu-
mented in the literatures and most cases of early PTLD, 
i.e., polymorphic lymphoid proliferations occurring with-
in one year of transplant, are related to primary infection 
with EBV or reactivation of previously acquired EBV. In 
contrast, late PTLD (as in our case) presents with histo-
logic features of non-Hodgkin lymphoma, most fre-
quently diffuse large B-cell lymphoma; and the majority of 
cases are not associated with EBV infection. Treatment of 
early (polygonal) PTLD should include a reduction or dis-
continuation of immunosuppressive agents. Rituximab 
has been used either as a single agent or in combination 
with other treatment modalities in the treatment of pati-
ents with early and late PTLD after solid organ transplan-
tation. Late (monoclonal) PTLD is generally unresponsive 
to a reduction in immunosuppression and should be treat-
ed with chemotherapy according to the underlying histo-
logic lymphoma subtype [9,10].
This is a very rare case of intussusception, associated 
with PTLD, in an adult liver transplant patient. In the clin-
ical setting of intestinal obstruction after liver transplant, 
this unusual cause of intestinal obstruction should be al-
ways considered.
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